Takahiro Sugimoto

USPTO Granted Patents = 35 (Patent Applications = 9)

EPO Patents = 14 (Patent Applications = 10)

Average Co-Inventor Count = 7.2

ph-index = 6

Forward Citations = 120(Granted Patents)

Location History:

Fujisawa, JP (2018)
Mie, JP (2021)
Kanagawa, JP (2016 - 2024)

Company Filing History:

33 out of 1,177

Takeda Pharmaceutical Company Limited

patents

2 out of 2,955

Toshiba Memory Corporation

patents

Years Active: 2016-2025

Loading Chart...

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12421188 - Heterocyclic compound and use thereof (2025-09-23),

2. 12415782 - Heterocyclic compound and use thereof (2025-09-16),

3. 12404237 - Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1'-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives (2025-09-02),

4. 12358879 - Heterocyclic compound (2025-07-15),

5. 12091410 - Heterocyclic compound (2024-09-17),

6. 12071434 - Heterocyclic compound (2024-08-27),

7. 11655241 - Heterocyclic compound and use thereof (2023-05-23),

8. 11440883 - Heterocyclic compound and use thereof (2022-09-13),

9. 11319286 - Heterocyclic compound and application thereof (2022-05-03),

10. 11164639 - Semiconductor memory device (2021-11-02),

11. 11018217 - Semiconductor device and method for manufacturing the same (2021-05-25),

12. 10899752 - 2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor (2021-01-26),

13. 10865200 - Nitrogen-containing heterocyclic compound (2020-12-15),

14. 10584097 - Heterocyclic compound and use thereof (2020-03-10),

15. 10548899 - Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activity (2020-02-04),

Title: Unveiling the Inventive Journey of Takahiro Sugimoto

Introduction:

Takahiro Sugimoto, a prolific inventor hailing from Kanagawa, Japan, has made significant contributions to the field of pharmaceuticals and medical treatments. With an impressive portfolio of 29 patents, Sugimoto's innovative work continues to shape the landscape of healthcare and pharmacology.

Latest Patents:

Among his recent patents is the groundbreaking discovery of a heterocyclic compound with orexin type 2 receptor agonist activity. This compound, represented by the formula (I), exhibits promising potential as an agent for the prophylaxis and treatment of narcolepsy, offering new hope for individuals suffering from this neurological disorder.

Career Highlights:

Sugimoto's professional journey has seen him lend his expertise to esteemed companies such as Takeda Pharmaceutical Company Limited and Toshiba Memory Corporation. Through his tenure at these organizations, Sugimoto has honed his skills and expanded his knowledge, paving the way for groundbreaking inventions in the realm of pharmaceuticals.

Collaborations:

Throughout his career, Takahiro Sugimoto has collaborated closely with talented individuals such as Hiroki Sakamoto and Makoto Kamata. Together, these innovators have synergized their talents and expertise to drive forward cutting-edge research and development initiatives, fostering a culture of innovation and discovery.

Conclusion:

In conclusion, Takahiro Sugimoto stands as a beacon of innovation in the field of pharmaceuticals, with his myriad patents and pioneering discoveries serving as a testament to his unwavering dedication to advancing scientific knowledge and improving healthcare outcomes. His inventive spirit and collaborative ethos continue to inspire future generations of inventors and researchers on the path to transformative discoveries in the world of medicine and beyond.

This text is generated by artificial intelligence and may not be accurate.